Fosun Pharma to acquire a 53% stake in Green Valley Pharmaceutical for $200m.

Synopsis

Fosun Pharma, a Chinese pharmaceutical company, agreed to acquire a 53% stake in Green Valley Pharmaceutical, a developer of Alzheimer's disease drugs, for $200m.

Principals

target

Green Valley Pharmaceutical Co

bidder

Shanghai Fosun Pharmaceutical

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context